Extracorporeal membrane oxygenation machine (ECMO) is a miniaturized and simplified form of heart-lung machines which is used as a support device in heart failure. This treatment is an option for patients undergoing a heart transplant or a lung transplant surgery. ECMO is used in the removal of blood and carbon dioxide from the person's body and oxygenating the red blood cells. Moreover, it is used in either in late stage treatment or post-cardiopulmonary bypass with a profound heart and/or lung failure.
The "Global Extracorporeal Membrane Oxygenation Machine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Extracorporeal Membrane Oxygenation Machine market with detailed market segmentation by modality, application and geography. The report provides key statistics on the market status of the leading Extracorporeal Membrane Oxygenation Machine market players and offers key trends and opportunities in the market.
- Based on Modality, the global Extracorporeal Membrane Oxygenation Machine market is segmented into Venoarterial, Venovenous and Arteriovenous.
- Based on Application , the global Extracorporeal Membrane Oxygenation Machine market is segmented into Cardiac Applications, Respiratory Applications and Extracorporeal Cardiopulmonary Resuscitation (ECPR).
- Rising prevalence of cardiovascular and respiratory diseases
- Growing number of ECMO centers
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Extracorporeal Membrane Oxygenation Machine market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Extracorporeal Membrane Oxygenation Machine market in these regions.
IMPACT OF COVID-19 ON EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. However, the demand for Extracorporeal Membrane Oxygenation Machine has increased due to rising in COVID instances. Thus, a Caire Inc, a US-based company is offering an innovative portable oxygen concentrator with Airsep. AirSep oxygen products is likely to care for critically ill patients during unprecedented time. Also, the company has increased production to meet the rapidly increasing demand for its oxygen therapy solutions as the world combats coronavirus (Covid-19). Therefore, the uses of Extracorporeal Membrane Oxygenation and growing demand for the extracorporeal membrane oxygenation in North America is likely to boost the growth of the Extracorporeal Membrane Oxygenation market.
The report covers key developments in the Extracorporeal Membrane Oxygenation Machine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Extracorporeal Membrane Oxygenation Machine market are anticipated to lucrative growth opportunities in the future with the rising demand for Extracorporeal Membrane Oxygenation Machine in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Extracorporeal Membrane Oxygenation Machine market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
1. MicroPort Scientific Corporation.
3. MAQUET Holding B.V. & Co. KG.
4. Getinge AB.
5. TERUMO CORPORATION
7. ALung Technologies, Inc.
9. OriGen Biomedical
10. LivaNova PLC
11. Hemovent GmbH
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.